Pharmaceutical company AstraZeneca has agreed to supply 9 million additional doses of its coronavirus vaccine to the European Union during the first quarter, the bloc's executive arm said Sunday. The new target of 40 million doses by the end of March is still only half what the British-Swedish company had originally aimed for, triggering a spat between AstraZeneca and the EU last week.from World News Headlines, Latest International News, World Breaking News - Times of India https://ift.tt/3pI1b88
Post a Comment